Literature DB >> 21489530

Growth factors and bone regeneration: how much bone can we expect?

Aaron Nauth1, Bill Ristevski, Ru Li, Emil H Schemitsch.   

Abstract

A large body of research has investigated the use of growth factors for bone regeneration, as a potential alternative to autogenous bone grafting. The bone morphogenetic proteins (BMPs) represent the most extensively investigated growth factors to date, as potential therapeutic agents for bone regeneration. Despite decades of research, the ideal growth factor or combination of growth factors for bone regeneration remains undefined. This article reviews the current available evidence for the application of growth factors for bone regeneration, with a focus on the clinical evidence for BMP use. Emerging pre-clinical and clinical evidence for growth factors other than the BMPs is also discussed.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2011        PMID: 21489530     DOI: 10.1016/j.injury.2011.03.034

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  18 in total

Review 1.  Strategies for controlled delivery of growth factors and cells for bone regeneration.

Authors:  Tiffany N Vo; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2012-02-04       Impact factor: 15.470

Review 2.  Clinical application of bone morphogenetic proteins for bone healing: a systematic review.

Authors:  Gopal Shankar Krishnakumar; Alice Roffi; Davide Reale; Elizaveta Kon; Giuseppe Filardo
Journal:  Int Orthop       Date:  2017-04-19       Impact factor: 3.075

Review 3.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part I: recapitulation of native tissue healing and variables for the design of delivery systems.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-02-19       Impact factor: 6.389

4.  Oxidized alginate hydrogels for bone morphogenetic protein-2 delivery in long bone defects.

Authors:  Lauren B Priddy; Ovijit Chaudhuri; Hazel Y Stevens; Laxminarayanan Krishnan; Brent A Uhrig; Nick J Willett; Robert E Guldberg
Journal:  Acta Biomater       Date:  2014-06-17       Impact factor: 8.947

5.  Role of isolated percutaneous autologous platelet concentrate in delayed union of long bones.

Authors:  Gipson Samuel; Jagdish Menon; Sreenivas Thimmaiah; Gayadhar Behera
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-11-22

6.  Controlled Release of Vanadium from a Composite Scaffold Stimulates Mesenchymal Stem Cell Osteochondrogenesis.

Authors:  S D Schussler; K Uske; P Marwah; F W Kemp; J D Bogden; S S Lin; Treena Livingston Arinzeh
Journal:  AAPS J       Date:  2017-03-22       Impact factor: 4.009

7.  In vitro characterization of a synthetic calcium phosphate bone graft on periodontal ligament cell and osteoblast behavior and its combination with an enamel matrix derivative.

Authors:  Richard J Miron; Dieter D Bosshardt; Anja C Gemperli; Michel Dard; Daniel Buser; Reinhard Gruber; Anton Sculean
Journal:  Clin Oral Investig       Date:  2013-04-26       Impact factor: 3.573

8.  Delivery vehicle effects on bone regeneration and heterotopic ossification induced by high dose BMP-2.

Authors:  Laxminarayanan Krishnan; Lauren B Priddy; Camden Esancy; Brett S Klosterhoff; Hazel Y Stevens; Lisa Tran; Robert E Guldberg
Journal:  Acta Biomater       Date:  2016-12-08       Impact factor: 8.947

9.  Emulsion cross-linked chitosan/nanohydroxyapatite microspheres for controlled release of alendronate.

Authors:  Hongwei Wu; Yan Xu; Gengyan Liu; Jianghong Ling; Biraja C Dash; Jianming Ruan; Chaoyue Zhang
Journal:  J Mater Sci Mater Med       Date:  2014-07-31       Impact factor: 3.896

10.  Accelerating protein release from microparticles for regenerative medicine applications.

Authors:  Lisa J White; Giles T S Kirby; Helen C Cox; Roozbeh Qodratnama; Omar Qutachi; Felicity R A J Rose; Kevin M Shakesheff
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2013-02-21       Impact factor: 7.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.